We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

92 hedge funds and large institutions have $285M invested in Utah Medical Products in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

14% more funds holding

Funds holding: 81 → 92 (+11)

11% more capital invested

Capital invested by funds: $256M → $285M (+$29.2M)

0.02% more ownership

Funds ownership: 69.32% → 69.34% (+0.02%)

Holders
92
Holders Change
+11
Holders Change %
+13.58%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
32
Reduced
25
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIM
Ranger Investment Management
Texas
+$2.68M
2
Lazard Asset Management
Lazard Asset Management
New York
+$2.66M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.62M
4
BlackRock
BlackRock
New York
+$1.76M
5
Invesco
Invesco
Georgia
+$1.66M

Top Sellers

Rank Fund Capital Flow
1
WCM Investment Management
WCM Investment Management
California
-$8.07M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.38M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.31M
4
AA
Ancora Advisors
Ohio
-$1.27M
5
CYG
Clean Yield Group
Vermont
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$441K – – –
PIM
52
Penobscot Investment Management
Massachusetts
$441K – – –
Cambridge Investment Research Advisors
53
Cambridge Investment Research Advisors
Iowa
$391K – – –
B
54
Bailard
California
$386K -$333K -3,193 -48%
RHJA
55
Rice Hall James & Associates
California
$377K +$6.06K +58 +2%
ASN
56
Advisory Services Network
Georgia
$374K +$17.8K +170 +5%
HW
57
Hancock Whitney
Mississippi
$369K +$2.3K +22 +0.7%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$360K +$14.2K +136 +4%
AllianceBernstein
59
AllianceBernstein
Tennessee
$352K +$62.7K +600 +23%
EHC
60
Everett Harris & Co
California
$329K -$58.5K -560 -16%
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$309K +$8.67K +83 +3%
Two Sigma Advisers
62
Two Sigma Advisers
New York
$297K +$62.7K +600 +29%
Two Sigma Investments
63
Two Sigma Investments
New York
$275K -$341K -3,266 -57%
Goldman Sachs
64
Goldman Sachs
New York
$268K +$254K +2,431 New
WI
65
WBI Investments
New Jersey
$260K +$246K +2,360 New
AIG
66
American International Group
New York
$247K +$5.64K +54 +2%
TRCT
67
Tower Research Capital (TRC)
New York
$235K +$223K +2,137 New
SRAM
68
Stone Ridge Asset Management
New York
$231K – – –
OSAM
69
O'Shaughnessy Asset Management
Connecticut
$228K +$218K +2,084 New
AQR Capital Management
70
AQR Capital Management
Connecticut
$227K +$216K +2,064 New
MIM
71
MetLife Investment Management
New Jersey
$221K – – –
Barclays
72
Barclays
United Kingdom
$207K -$34.3K -328 -15%
Millennium Management
73
Millennium Management
New York
$201K +$191K +1,828 New
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$148K – – –
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$110K – – –
1 2
3
4

UTMD Hedge Fund Activity: Q2 2018 in Review

92 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2018, worth a combined $285M — up 11% from $256M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new UTMD positions and 2 closed out — a net gain of 11 holders — while 32 added to existing stakes and 25 trimmed.

The largest buyer was Ranger Investment Management, opening a new position worth an estimated $2.68M. The largest seller was WCM Investment Management, exiting entirely with an estimated $8.07M sold.

  • 92 institutional investors held Utah Medical Products (UTMD) as of Q2 2018, up from 81 in Q1 2018.
  • Funds reported $285M of Utah Medical Products stock for Q2 2018, up 11% quarter-over-quarter.
  • 13 funds opened new Utah Medical Products positions in Q2 2018 and 2 closed out, a net change of +11 holders.
  • The largest Utah Medical Products buyer in Q2 2018 was Ranger Investment Management, an estimated $2.68M added.
  • The largest Utah Medical Products seller in Q2 2018 was WCM Investment Management, an estimated $8.07M sold.

Based on aggregated 13F filings for Q2 2018.